Substance
RILPIVIRINE HYDROCHLORIDE
Global reference: every product and company linked to this substance.
- cas: 700361-47-3
- ncit: C152217
- pubchem_cid: 11711114
- rxnorm: 1102287
- unii: 212WAX8KDD
Edurant · Edurant PED · Eviplera component rilpivirine hydrochloride · Juluca component rilpivirine hydrochloride · Rilpivirine hydrochloride [JAN] · Rilpivirine hydrochloride [USAN] · Rilpivirine hydrochloride [WHO-DD] · TMC-278 hydrochloride · TMC278 hydrochloride
Revenue by product (3)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| JOHNSON & JOHNSON COMMON STOCK | EDURANT | Q2 2026 | $350.0M |
| GILEAD SCIENCES INC. COMMON STOCK | ODEFSEY | Q2 2026 | $239.0M* |
| GILEAD SCIENCES INC. COMMON STOCK | COMPLERA | Q4 2023 | $25.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (5)
- COMPLERA · GILEAD SCIENCES INC. COMMON STOCK
- EDURANT · JOHNSON & JOHNSON COMMON STOCK
- EDURANT PED · JOHNSON & JOHNSON COMMON STOCK
- EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE · VIATRIS INC. COMMON STOCK
- ODEFSEY · GILEAD SCIENCES INC. COMMON STOCK